You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 16, 2024

~ Buy the DUOBRII (halobetasol propionate; tazarotene) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR DUOBRII

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DUOBRII

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04119102 ↗	Duobrii in Combination With Biologics	Recruiting	Ortho Dermatologics	Phase 4	2019-10-14	12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic therapy for at least 24 weeks
NCT04119102 ↗	Duobrii in Combination With Biologics	Recruiting	Psoriasis Treatment Center of Central New Jersey	Phase 4	2019-10-14	12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic therapy for at least 24 weeks
NCT04720105 ↗	Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis	Recruiting	Bausch Health Americas, Inc.	Phase 4	2020-11-19	The purpose of this research study is to examine the effect of Duobrii® (halobetasol propionate 0.01%/tazarotene 0.045% lotion, HP/TAZ) on plaque type psoriasis of the hands and/or feet.
NCT04720105 ↗	Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis	Recruiting	Icahn School of Medicine at Mount Sinai	Phase 4	2020-11-19	The purpose of this research study is to examine the effect of Duobrii® (halobetasol propionate 0.01%/tazarotene 0.045% lotion, HP/TAZ) on plaque type psoriasis of the hands and/or feet.
NCT05203315 ↗	Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults	Not yet recruiting	OrthoDermatologics	Phase 3	2022-01-17	This study seeks to evaluate the safety, tolerability, and efficacy of topical Duobrii® Lotion in adult subjects with mild plaque psoriasis.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DUOBRII

Condition Name

Chart
Table

Condition Name for DUOBRII
Intervention	Trials
Plaque Psoriasis	3
Acne Keloidalis Nuchae	1
AKN	1
Palmoplantar Psoriasis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DUOBRII
Intervention	Trials
Psoriasis	5
Acne Keloid	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DUOBRII

Trials by Country

Map
Table

Trials by Country for DUOBRII
Location	Trials
United States	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DUOBRII
Location	Trials
North Carolina	2
New York	2
New Jersey	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DUOBRII

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DUOBRII
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	2
Early Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DUOBRII
Clinical Trial Phase	Trials
Recruiting	4
Completed	1
Not yet recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DUOBRII

Sponsor Name

Chart
Table

Sponsor Name for DUOBRII
Sponsor	Trials
Ortho Dermatologics	2
Bausch Health Americas, Inc.	2
Icahn School of Medicine at Mount Sinai	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DUOBRII
Sponsor	Trials
Other	6
Industry	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.